[Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells

Detalles Bibliográficos
Autores principales: Taglieri, Ludovica, De Iuliis, Francesca, Giuffrida, Anna, Giantulli, Sabrina, Silvestri, Ida, Scarpa, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398620/
https://www.ncbi.nlm.nih.gov/pubmed/37545622
http://dx.doi.org/10.3892/ol.2023.13938
_version_ 1785084091888041984
author Taglieri, Ludovica
De Iuliis, Francesca
Giuffrida, Anna
Giantulli, Sabrina
Silvestri, Ida
Scarpa, Susanna
author_facet Taglieri, Ludovica
De Iuliis, Francesca
Giuffrida, Anna
Giantulli, Sabrina
Silvestri, Ida
Scarpa, Susanna
author_sort Taglieri, Ludovica
collection PubMed
description
format Online
Article
Text
id pubmed-10398620
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-103986202023-08-04 [Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells Taglieri, Ludovica De Iuliis, Francesca Giuffrida, Anna Giantulli, Sabrina Silvestri, Ida Scarpa, Susanna Oncol Lett Retraction D.A. Spandidos 2023-07-03 /pmc/articles/PMC10398620/ /pubmed/37545622 http://dx.doi.org/10.3892/ol.2023.13938 Text en Copyright: © Taglieri et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Retraction
Taglieri, Ludovica
De Iuliis, Francesca
Giuffrida, Anna
Giantulli, Sabrina
Silvestri, Ida
Scarpa, Susanna
[Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells
title [Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells
title_full [Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells
title_fullStr [Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells
title_full_unstemmed [Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells
title_short [Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells
title_sort [retracted] resistance to the mtor inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398620/
https://www.ncbi.nlm.nih.gov/pubmed/37545622
http://dx.doi.org/10.3892/ol.2023.13938
work_keys_str_mv AT taglieriludovica retractedresistancetothemtorinhibitoreverolimusisreversedbythedownregulationofsurvivininbreastcancercells
AT deiuliisfrancesca retractedresistancetothemtorinhibitoreverolimusisreversedbythedownregulationofsurvivininbreastcancercells
AT giuffridaanna retractedresistancetothemtorinhibitoreverolimusisreversedbythedownregulationofsurvivininbreastcancercells
AT giantullisabrina retractedresistancetothemtorinhibitoreverolimusisreversedbythedownregulationofsurvivininbreastcancercells
AT silvestriida retractedresistancetothemtorinhibitoreverolimusisreversedbythedownregulationofsurvivininbreastcancercells
AT scarpasusanna retractedresistancetothemtorinhibitoreverolimusisreversedbythedownregulationofsurvivininbreastcancercells

Ejemplares similares